7-(2-imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
US6423724B1 · kind B1 · utility
2Cited by
10References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 1998 |
| Grant date | Jul 23, 2002 |
| Priority date | — |
| Expiry date | Sep 24, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention involves involves the use of compounds having the following structure: wherein:(a) R is unsubstituted C1-C3 alkanyl or alkenyl; and(b) R′ is selected from hydrogen; unsubstituted C1-C3 alkanyl or alkenyl; unsubstituted C1-C3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo;for preventing or treating of disorders modulated by alpha-2 adrenoceptors.The subject invention also involves novel compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.